Study Information

What’s involved?

  • 3 outpatient appointments
  • No overnight stay!

About the study

This study is looking at a potential treatment for RSV (Respiratory Syncytial Virus) which affects infants (children aged 6 months to 5 years old) and the elderly. RSV causes infection of the lungs and airways. In Adults, RSV often presents with the symptoms of a common cold, although in infants and the elderly, the disease can affect the lungs, heart, or immune system.

Currently there is no vaccine currently available to prevent RSV infection, so it is hoped that this potential treatment may be of use to teat RSV infections in the future.

How do I find out more?

If you are interested in participating or would like more information, please register below.

If you have already registered with us but would like more information regarding this study, please call 1800 243 733 or email reply@nucleusnetwork.com.au and quote “Minimal Vaccination Study”.

  • 3
    Outpatient Visits

Minimum Eligibility Requirements:

  • Healthy Males and Females
  • Aged 18 - 45 years old
  • Body Mass Index 18 – 40kg/m²
  • Not taking any prescription medications (contraception, antidepressants & reflux medications OK)
Top